The Calmer Co International Limited (ASX:CCO)

Market Cap	12.23M
Revenue (ttm)	8.03M +88.5%
Net Income	-3.99M
EPS	-0.00
Shares Out	3.06B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,747,487
Average Volume	5,268,589
Open	0.0040
Previous Close	0.0040
Day's Range	0.0040 - 0.0050
52-Week Range	0.0020 - 0.0070
Beta	0.52
RSI	50.44
Earnings Date	Aug 29, 2025

About ASX:CCO

The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, the United States, and internationally. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; flavoured and non-flavoured kava shots, tinctures, and traditional and instant drinking kava under the Taki Mai brand name; hemp, CBD oils, topical salves, and pet CBD oils under Danodan brand name. It also markets Leilo kava beverages. In addition, it sells its products through retailers and online. The company wa...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CCO

Financial Performance

In 2025, ASX:CCO's revenue was 8.03 million, an increase of 88.48% compared to the previous year's 4.26 million. Losses were -3.99 million, 7.13% more than in 2024.